Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H10N4OS |
Molecular Weight | 234.278 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(=O)\C(=N\NC(N)=S)C2=C1C=CC=C2
InChI
InChIKey=DLGSOJOOYHWROO-XYOKQWHBSA-N
InChI=1S/C10H10N4OS/c1-14-7-5-3-2-4-6(7)8(9(14)15)12-13-10(11)16/h2-5H,1H3,(H3,11,13,16)/b12-8+
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14171075
The present recommendations are that adults should receive 6 g. methisazone (four capsules of Marboran) a day, taken 3 g. in the morning and 3 g. in the evening. Dosage is halved for children between 3 and 10 and proportionately reduced still
further for infants.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QJ05AA01
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
||
|
WHO-ATC |
J05AA01
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5357051
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
METISAZONE
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
DB13641
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
217-616-2
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
70969
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
DTXSID7046413
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
1742
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
1910-68-5
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
CHEMBL362994
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
C77928
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
K3QML4J07E
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
m7319
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | Merck Index | ||
|
69811
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
SUB08895MIG
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
1746
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY | |||
|
100000080935
Created by
admin on Fri Dec 15 15:10:32 GMT 2023 , Edited by admin on Fri Dec 15 15:10:32 GMT 2023
|
PRIMARY |
ACTIVE MOIETY